Bad Medicine
Rick D #39;Alessandro earned his medical degree graduating from a top Medical School. And Rick #39;s first job was as good as it gets until he discovered his boss, a...

By: idfullepisodes

Go here to read the rest:

Bad Medicine - Video

Mistress of Medicine
After throwing a disastrous birthday party, Mariah tries to make things right with the ladies but Quad goes on the attack. When Kari and Mariah decide to thr...

By: BravoShows

Go here to see the original:

Mistress of Medicine - Video

My Hair Is Layed Like Quad Webb-Lunceford (BRAVO #39;s Married To Medicine ep 1-2 review)
http://www.FunkyDineva.com.

By: beeper246

See the rest here:

My Hair Is Layed Like Quad Webb-Lunceford (BRAVO's Married To Medicine ep 1-2 review) - Video

Concierge Medicine Today, chooses only a few select physicians in the concierge medicine and/or direct pay business model environment across the U.S. each year who meet the criteria to qualify as a Top Doc. This year, they selected only 15.

ATLANTA, GA (PRWEB) April 03, 2013

"We feel it is very important to acknowledge and recommend specific practices within the concierge medical and direct primary care marketplace that reflect and represent the care, value and benefits of this industry," said Michael Tetreault, Editor-In-Chief of Concierge Medicine Today. "What makes this year unique is we have more seasoned physicians in specialties other than primary care. They are operating in more rural areas than weve seen in the past.

We look for physicians each year who have made an impact on patients, their community, their State, social media, technology and more. There are so many great doctors to choose from each year. In 2013, we found doctors who are opening up extraordinary practices in markets like Kansas, Montana, Utah, Vermont and even Bismarck, North Dakota, says Tetreault.

Criteria Evaluated for Concierge Medicine Todays TOP DOCS 2013 Recognition and Nomination Includes (but is not limited to...)

Educational Efforts (ie. about concierge medicine/direct care)

Patient Ratings/Reviews

Value-Added Services Inside Their Practice

Innovative Services/Marketing

Charitable Efforts

Here is the original post:

The Top Docs in Concierge Medicine of 2013 Honored by Concierge Medicine Today

MEDICINE HAT, AB, April 3, 2013 /CNW/ - The Government of Canada is providing support for Medicine Hat youth to help them gain the skills, knowledge and experience they need to enter and succeed in the job market. The announcement was made by LaVar Payne, Member of Parliament for Medicine Hat, on behalf of the Honourable Diane Finley, Minister of Human Resources and Skills Development.

"Our government's top priorities are creating jobs, economic growth and long-term prosperity," said Mr. Payne. "The Government of Canada's Youth Employment Strategy is helping youth develop the skills and gain the experience they need to get jobs now and prepare for the workforce of tomorrow."

The Medicine Hat Family YMCA is receiving more than $556,000 from the Skills Link program to help youth overcome barriers to employment. Skills Link is part of the Government of Canada's Youth Employment Strategy (YES).

Through workshops, participants will gain valuable life and job skills including budgeting and teamwork. They will also benefit from on-the-job experience with employers, based on their career goals and development plans.

The Medicine Hat Family YMCA is grateful to the Government of Canada for this funding," said Jim Smith, CEO, Medicine Hat Family YMCA. "This continued support will enable us to provide unemployed youth in the Medicine Hat region with life skills, employment training and job placements."

With an annual budget of more than $300 million, YES helps youth, particularly those facing barriers to employment, obtain career information, develop employment skills, find jobs and stay employed. YES includes the Skills Link and Career Focus programs and the Canada Summer Jobs initiative, which creates thousands of job opportunities for students every summer.

Economic Action Plan 2012 provided an extra $50 million over two years to enhance YES with a new initiative that connects young Canadians with jobs that are in high demand and helps them develop tangible skills and gain work experience. Economic Action Plan 2013 proposes an additional investment of $70 million over three years to support 5,000 more paid internships.

Youth employment programs are part of the Government of Canada's broader strategy to create an educated, skilled and flexible workforce. The Government underscored its commitment to this strategy in Canada's Economic Action Plan. A key component of the Plan is to create more and better opportunities for Canadian workers through skills development. To learn more about Canada's Economic Action Plan, visit actionplan.gc.ca.

The Government of Canada is helping youth plan their careers, learn new skills and find jobs through enhanced online services available at youth.gc.ca.

Backgrounder

See the original post here:

Government of Canada invests to help youth in Medicine Hat get jobs

DALLAS, April 3, 2013 /PRNewswire/ --

The European Nuclear Medicine / Radiopharmaceuticals Market[SPECT/PET Radioisotopes (Technetium, F-18)], [Beta/Alpha radiation therapy (I131, Y-90)], [Applications (Cancer/Oncology, Cardiac)] & Stable Isotopes (Deuterium, C-13) - Global Trends & Forecast to 2017].

Browse >>

http://www.marketsandmarkets.com/Market-Reports/european-nuclear-medicine-radiopharmaceuticals-market-1107.html

Early buyers will receive 10% customization on this report.

This report studies the European nuclear medicine market over the forecast period 2012-2017.

The European radiopharmaceutical market was valued at $1.1 billion in 2012 and is poised to reach $1.6 billion by 2017 at a CAGR of 6.8%.

The radioisotopes market is categorized into diagnostic and therapeutic applications. The diagnostic market consists of PET and SPECT technologies, while the therapy market comprises of beta emitters and brachytherapy seeds. The SPECT market accounted for a major share of the diagnostic segment in 2012. Significant radioisotopes in the SPECT diagnostic market are Tc-99m, Tl- 201, Ga-67, and I-123, while PET market is dominated by F-18 and Rb-82. The therapy market is led by I-131, Sm-153, Re-186, Y-90, and Lu-177. Alpha emitters are being developed and considered for cancer treatment, however not available commercially.

It is estimated that Tc-99m diagnostic procedures are expected to increase by more than 15% in mature markets of Europe, and other developed regions between 2010 and 2030, however shortage of Mo-99/Tc-99m has been a threat to this industry. The scheduled shutdown of the NRU reactor in Canada in 2016 and OSIRIS in France in 2018 is a major risk for manufacturers in the near future. Companies have increased the production of thallium to meet the shortage, as it is the most commonly used substitute for technetium-99 in cardiac-stress tests, conducted to evaluate the functioning of coronary arteries. Radiopharmaceuticals in neurological applications such as Alzheimer's disease, Parkinson's disease, and dementia are also being preferred by practitioners besides conventional treatment. Further, upcoming radioisotopes such as Ra-223 (Alpharadin) and Ga-68 possess huge potential for clinical applications.

Increasing use of SPECT and PET scans, technical advancements in equipment and other factors such as rising awareness of radiopharmaceuticals among physicians, alpha radioimmunotherapy based targeted cancer treatment, and ready availability of radiopharmaceutical from cyclotrons have driven the market. High cost of devices using radioisotopes, short half-life, lack of good manufacturing practices, and stringent regulatory approvals are major hurdles to growth of the market.

See more here:

European Nuclear Medicine / Radiopharmaceuticals Market Worth by Reach $1.6 Billion by 2017

CHEVY CHASE, Md.--(BUSINESS WIRE)--

Precision for Medicine, Inc., formed in 2012 to support next-generation approaches to drug development and commercialization, today announced that it has secured $150 million in private equity financing to support acquisitions and development. Precision for Medicine is building a comprehensive platform of specialized development and commercialization services to support life science companies that are seeking to capitalize on the benefits of patient centered, precision medicine. Oak Investment Partners, J.H. Whitney and Company along with Precisions Co-Founders Ethan D. Leder and Mark P. Clein provided the financing.

Ethan D. Leder and Mark P. Clein, co-founders of the Maryland-based company, said the funding will be used to acquire the expertise and infrastructure necessary to guide innovative medical products from discovery to patients. Precision for Medicine is the most recent endeavor in a series of highly successful health care businesses the two have created over the past 20 years. Their most recent company, Chevy Chase, MD based United BioSource Corporation, employed approximately 1,600 researchers prior to its sale to Medco Health Solutions (NYSE-MHS) in 2010 for an estimated $750 million.

Next generation medicine is about placing greater emphasis on the patient as the focal point of all product development activity, says Ethan D. Leder, CEO. Life science companies that are moving to embrace precision medicine will fundamentally improve the efficiency of drug development and will deliver products that offer better results for patients. Our mission is to build the services and infrastructure to support life science innovators as they develop new products that deliver the best outcomes to patients.

This financing will allow us to aggressively acquire and grow a unique portfolio of capabilities designed to deliver lower development costs, speed the time to market, and improve success rates, said Mark P. Clein, President. Precision for Medicines growing team of over 130 employees includes recognized experts in regulatory sciences, clinical development, commercialization, and product strategy. Precisions experts collaborate with clients to speed approval, reduce costs, and optimize market launch through solutions that combine innovative approaches to patient selection with a deep understanding of payers, regulators, science, and policy.

Precision also provides next generation bioservices solutions including biorepository, sample management and cellular productsfrom its state-of-the-art biorepository facilities in Frederick and Gaithersburg, MD managing more than 15 million samples.The Precision Bioservices team has a distinguished reputation and many long-term relationships with life science and academic research institutions, including the US Governments National Institutes of Health.

About Precision for Medicine

Precision for Medicine is a specialized service company providing services and infrastructure to support life science companies as they develop new products in the age of precision medicine. Precision brings expertise, technology and project execution to support innovative, patient centric solutions from discovery through commercialization. The company is headquartered in Chevy Chase, MD with offices in Gaithersburg, MD, Frederick, MD and Cambridge, MA. For more information about Precision, visitwww.precisionformedicine.com.

Read more:

Precision for Medicine Raises $150 Million to Fund Growth and Expansion

CAMBRIDGE, Mass.--(BUSINESS WIRE)--

Foundation Medicine, Inc., and Agios Pharmaceuticals, Inc., today announced a multi-year diagnostic partnership for Agios lead programs in cancer metabolism. These programs focus on developing new cancer metabolism inhibitors targeting tumors carrying mutations in either the IDH1 or IDH2 metabolic enzymes. Foundation Medicine and Agios are collaborating to identify tumor genomic alterations that can be used to identify which patients are most likely to respond to Agios IDH1 and IDH2 drug candidates, and to develop and potentially commercialize diagnostic products for these programs.

Our lead IDH1 and IDH2 programs demonstrate Agios ability to leverage deep understanding of cancer metabolism to design first-in-class cancer medicines for genetically defined patient populations, said David Schenkein, M.D., chief executive officer of Agios. As we prepare to enter the clinic, Foundation Medicine provides us with the most advanced genomic profiling and analytical expertise in the industry. This collaboration will further expand our insights on how best to target IDH mutations therapeutically and will help us in our mission to bring important new drugs to patients with cancer.

Agios is forging a new and different path to cancer treatment by targeting cancer metabolism, said Michael J. Pellini, M.D., chief executive officer of Foundation Medicine. Foundation Medicines comprehensive cancer genomic profile helps match a patients individual molecular alterations with relevant targeted therapies. For this reason, it is important for us to partner with innovative biopharmaceutical companies like Agios to help expand the number of targeted therapies available and open new treatment options for patients.

About Agios Pharmaceuticals, Inc.

Agios is the leading biopharmaceutical company focused on discovering and developing novel drugs in the fields of cancer metabolism and rare metabolic genetic diseases. In addition to an active research and discovery pipeline across both therapeutic areas, Agios has multiple first-in-class programs in cancer metabolism and inborn errors of metabolism advancing toward the clinic. All Agios programs focus on genetically identified patient populations leveraging our knowledge of metabolism, biology and genomics. For more information, please visit our website at http://www.agios.com.

David Schenkein, M.D., chief executive officer of Agios Pharmaceuticals, is also a member of the board of directors of Foundation Medicine.

About Foundation Medicine

Foundation Medicine is a molecular information company dedicated to a transformation in cancer care in which treatment is informed by a deep understanding of the genomic changes that contribute to each patients unique cancer. The companys initial clinical assay, FoundationOneTM, is a fully informative genomic profile to identify a patients individual molecular alterations and match them with relevant targeted therapies and clinical trials. Foundation Medicines molecular information platform aims to improve day-to-day care for patients by serving the needs of clinicians, academic researchers and drug developers to help advance the science of molecular medicine in cancer. For more information, please visit http://www.foundationmedicine.com or follow Foundation Medicine on Twitter (@FoundationATCG).

Foundation Medicine is a registered trademark, and FoundationOneTM is a trademark of Foundation Medicine, Inc.

Link:

Foundation Medicine and Agios Announce Diagnostic Discovery Collaboration for IDH1 and IDH2 Cancer Metabolism Programs

MIRAMAR, Fla.--(BUSINESS WIRE)--

Ross University School of Medicine (RUSM) today announced a new affiliation agreement with Atlanta Medical Center (AMC) that will enable RUSM students to complete required clinical rotations in family practice, internal medicine, pediatrics, psychiatry, obstetrics and gynecology and surgery at the Atlanta teaching hospital.

Dr. Joseph Flaherty, dean and chancellor at RUSM, said AMC fits well with the schools model of an ideal teaching affiliate. Atlanta Medical Center shares with Ross University School of Medicine a commitment to teaching and a sense of obligation to serve a diverse community. The high caliber of the hospitals graduate medical education programs gives us confidence that students who rotate through AMC will receive great preparation for residency.

Atlanta Medical Center is a 762-bed acute care hospital and a leading provider of advanced medical care to the metro Atlanta area. It is the second largest licensed-bed hospital in Georgia and a Level 1 trauma center. Atlanta Medical Centers services include surgery, neurology, oncology and orthopedics. The hospital is widely recognized for its womens services program and for outstanding performance in the treatment of stroke patients. Its weight-loss program is designated as a Bariatric Surgery Center of Excellence. The hospital has campuses in downtown Atlanta and East Point, GA.

AMCs programs in internal medicine, general surgery, orthopedic surgery, and family medicine are approved by the Accreditation Council for Graduate Medical Education (ACGME).

AMC welcomed Ross students in December 2012, and the hospital will become a track rotation affiliate in the spring. This allows Ross students placed there to complete all of their third-year clinical rotations over 48 consecutive weeks. Currently, more than 180 Ross students are from Alabama, Georgia, South Carolina and Tennessee.

Atlanta Medical Center is pleased to offer this training to RUSM students, said Dr. Steven Saltzman, medical director for RUSM Medical Student Education. We have a history of training the next generation of doctors, and our programs will ensure that Ross students are well prepared for a career in medicine.

Atlanta Medical Center is a great addition to our network of teaching affiliates and will be an anchor location for RUSM students desiring to complete their medical education in the Southeast, said Flaherty.

RUSM students begin their journey to become physicians on the schools campus in Dominica, located in the West Indies. Students complete a rigorous, four-semester accelerated study program in the basic sciences. The campus features a cutting-edge anatomy and medical imaging laboratory, as well as a simulation center where students begin to develop clinical skills. Students then complete their medical education by taking core and elective clinical rotations in one of RUSMs teaching affiliates across the United States. Over the last year, RUSM has accelerated efforts to strengthen its network of affiliates.

In recent months, RUSM has begun or expanded clinical education affiliations with a number of highly regarded teaching hospitals. In May, RUSM entered into a 10-year affiliation agreement with Kern Medical Center in Bakersfield, Calif., which provides about 100 core clinical rotation slots annually to RUSM students. That partnership is the largest clinical affiliation in RUSMs history. RUSM also has added rotations recently at Cleveland Clinic and Memorial Regional Hospital, both in South Florida, California Hospital Medical Center in Los Angeles, Calif., and Vanguard MacNeal Hospital in Berwyn, Ill a suburb of Chicago.

View post:

Ross University School of Medicine Establishes Education Agreement with Atlanta Medical Center

23 Twitter Facebook Email

An estimated 1 million or more patients are harmed in America's hospitals every year. Join doctors and patient safety advocates for a discussion on accountability and spurring improvement.

by Blair Hickman ProPublica, Apr. 1, 2013, 3:20 pm

More than 1 million patients suffer harm each year while being treated in the U.S. health care system. Even more receive substandard care or costly overtreatment.

In 1999, the Institute of Medicine released a report suggesting a strategy to combat death due to preventable medical errors and set a goal of cutting preventable errors in half over the next five years.

Nearly 15 years later, several problems cited in the report are still an issue. The publicdoesntknow if deaths due to preventable errors have decreased, because noone agency tracks them (which was actually a recommendation in the report). And to complicate matters, deaths due to preventable error are just a subset of the problem: an estimated 1 million people or more are harmed in the hospital every year, from infections to injuries to surgical mistakes.

So why does the patient harm problem persist? Is it bad systems, or are individuals also responsible? And how can health care providers and the public promote accountability? Join ProPublica for a discussion this Friday, April 5, at 1 PM ET with Dr. Marty Makaryof Johns Hopkins, SorryWorks! founder Doug Wojcieszak, UCLAs Dr. Clifford Ko and health care journalist Marshall Allen.

You can tweet questions for our panel in advance with the hashtag #MedErrorsChat, or leave them in the comments below.

As social media producer, Blair Hickman leads ProPublica's health care, financial and education communities.

2174884 searches

More:

Discussion: How to Improve Accountability in Medicine ?

A senior official at the Saudi Food and Drug Administration (SFDA) has said that its administration has identified 11 outlets out of a total of 33 that act as legitimate portals for medicine into the country.

The SFDA aims to regulate the entry of medicine into the Saudi market by blocking counterfeit products into pharmacies, the official said, adding that the 11 outlets are staffed with qualified pharmacists who take samples for testing to ensure product safety.

The SFDA monitors each and every drug-type entering the Saudi market via an electronic system that allows medicine to pass through, said Dr. Saleh bin Abdullah Bawazir, vice president of the Drug Sector at the SFDA.

He explained that the system records whether medicine is produced locally or imported, as well as recording their serial numbers and the party responsible for authorization of their entrance into the country.

Qualified pharmacists at the SFDA ensure the quality of any imported drug at every outlet, as well as their compliance with registration terms, added Bawazir. In addition, the SFDA conducts field inspection tours at all warehouses across the Kingdom.

An annual project will be established to check all counterfeit medicine throughout the country. The task of monitoring and inspecting private pharmacies is still the responsibility of the Health Ministry, he said.

Bawazir said that SFDA does not have the power to block the marketing of any medicine in the private sector. Nevertheless, there are strict regulations that demand all pharmacies to keep vouchers that display the country of origin for each medicine in their possession.

He said that the SFDA intends to establish a special department to fight counterfeiting, cheating and drug-related complaints.

The process of importation, storage and selling is confined to licensed agents who then distribute them to pharmacies with the coordination of SFDA inspectors, he added.

Selling medicine online is prohibited in the Kingdom as per the SFDA. There are special procedures and regulations that govern the process of speedy shipment of medicine, he said.

View original post here:

Action sought against ‘suitcase traders’ of medicine

TORONTO - Patients receiving acupuncture, herbal remedies or other forms of traditional Chinese medicine in Ontario will soon gain some reassurance that those treating them are qualified to do so.

The College of Traditional Chinese Medicine Practitioners and Acupuncturists of Ontario will begin regulating traditional Chinese medicine on April 1.

The passing of the Traditional Chinese Medicine Act in 2006 created the self-regulatory body which will now demand that every practitioner register with the college after passing a series of tests or displaying that they have equivalent experience after having seen at least 2,000 patients in the last five years.

The college will also handle complaints from the public.

Practitioners had to have their registration forms submitted by March 19th in order to be able to practice on April 1.

Emily Cheung, the college's registrar, said the new regulations will allow the public to be assured that every practitioner treating them has met certain standards.

"Right now, there are no rules or policies and individuals can practice however they choose," said Cheung. "The public does not know whether a person is qualified or not because anyone can call themselves a traditional Chinese medicine doctor."

The new rules make Ontario one of just two provinces in Canada to regulate traditional Chinese medicine. British Columbia put its own set of rules in place in April 2003.

Traditional Chinese medicine is an ancient treatment that focuses on acupuncture, herbal remedies, proper nutrition and Chinese massage to balance the yin and yang or contrary forces in one's system.

Not all practitioners study in a school setting as learning the treatments from ancestors is a frequent practice in China.

Follow this link:

Traditional Chinese medicine to be regulated in Ontario, registration needed

Beginning today, patients receiving acupuncture, herbal remedies or other forms of traditional Chinese medicine in Ontario will have some reassurance that those treating them are qualified to do so.

The College of Traditional Chinese Medicine Practitioners and Acupuncturists of Ontario will begin regulating traditional Chinese medicine today.

Acupuncturist Mable Cheung of Windsor, Ont., said the changes are in the best interest of the public.

"A lot of times, people are Googling acupuncture, and Chinese medical practitioners and blindly choosing someone hoping theyre licensed," she said.

One of Cheung's patients, Denise Jacobs, has been receiving acupuncture treatment for her insomnia. She thought the industry was already government regulated and welcomes the change.

"I never put any thought into it, actually," she said. "I think its quite a good thing. Its very important youre guided in the right direction."

The passing of the Traditional Chinese Medicine Act in 2006 created the self-regulatory body which will now demand that every practitioner register with the college after passing a series of tests or displaying that they have equivalent experience after having seen at least 2,000 patients in the last five years.

The college will also handle complaints from the public.

Practitioners had to have their registration forms submitted by March 19 in order to be able to practice on April 1.

Emily Cheung, the college's registrar, said the new regulations will allow the public to be assured that every practitioner treating them has met certain standards.

Go here to see the original:

Traditional Chinese medicine now regulated in Ontario

By Genevra Pittman

NEW YORK (Reuters Health) - Telling the parents of babies who spit up and cry frequently that their child has gastroesophageal reflux disease, or GERD, makes them more likely to want medicine - even if they're also told it isn't likely to help much, a new study suggests.

Most babies who spit up don't have an acid reflux problem, researchers said, just a not-quite-developed upper stomach valve.

Still, an increasing number of those kids are being labeled as having GERD - even though a definitive diagnosis normally requires an invasive test.

"Roughly 50 percent of babies during the first six months are spitting up enough to bother their parents," said Dr. William Carey from The Children's Hospital of Philadelphia, who wrote a commentary published Monday with the new study.

"I never offered medication for a kid who was just spitting up and gaining weight well and happy," he told Reuters Health. "I could confidently tell the mother, Look, it's going to be a nuisance until about six months, and then it's gradually going to get better.' It's an irritating variation of normal."

For their study, Laura Scherer from the University of Missouri in Columbia and her colleagues handed out surveys to 175 parents with a hypothetical scenario: their one-month-old infant was spitting up and crying a lot.

The researchers asked parents what they would do if the doctor diagnosed their child with GERD versus if the condition wasn't labeled, as well as what they would do if the doctor told them the medication to treat the condition was ineffective - as research suggests it is - or didn't say anything about its efficacy.

Survey participants were more likely to want medication if their hypothetical infant was given a GERD diagnosis. Even when parents were told the medicine probably wouldn't work, they rated their interest in treatment at about 2.5 out of 5.

However, with no disease label and with information about the medicine's lack of efficacy, parents rated their desire to treat below 1.5 out of 5, the researchers reported in Pediatrics.

See the original post here:

GERD label makes parents more likely to want medicine

DALLAS, April 1, 2013 /PRNewswire/ --

TheNuclear Medicine/ Radiopharmaceuticals Market[SPECT/PET Radioisotopes (Technetium, F-18)], [Beta/Alpha Radiation Therapy (I131, Y-90)], [Applications (Cancer/Oncology, Cardiac)] & Stable Isotopes (Deuterium, C-13)-Global Trends & Forecast To 2017analyzes and studies the major market drivers, restraints, and opportunities in North America, Latin America, Europe, Asia, and Rest of the World.

Browse

http://www.marketsandmarkets.com/Market-Reports/radiopharmaceuticals-market-417.html

Early buyers will receive 10% customization on this report.

This report studies the global nuclear medicine market over the forecast period 2012-2017.

The global radiopharmaceutical market was valued at $3.8 billion in 2012 and is poised to reach $5.5 billion by 2017 at a CAGR of 7.8%.

The radioisotopes market is categorized into diagnostic and therapeutic applications. The diagnostic market consists of PET and SPECT technologies, while the therapy market comprises of beta emitters and brachytherapy seeds. The SPECT market accounted for a major share of the diagnostic segment in 2012. Significant radioisotopes in the SPECT diagnostic market are Tc-99m, Tl- 201, Ga-67, and I-123, while PET market is dominated by F-18, and Rb-82. The therapy market is led by I-131, Sm-153, Re-186, Y-90, and Lu-177. Alpha emitters are being developed and considered for cancer treatment, however not available commercially.

It is estimated that Tc-99m diagnostic procedures are expected to increase by more than 15% in mature markets of North America, Europe, Japan, the Republic of Korea, and Oceania between 2010 and 2030, however shortage of Mo-99/Tc-99m has been a threat to this industry. The scheduled shutdown of the NRU reactor in 2016 and OSIRIS in France in 2018 is a major risk for manufacturers in the near future. Companies have increased the production of thallium to meet the shortage, as it is the most commonly used substitute for technetium-99 in cardiac-stress tests, conducted to evaluate the functioning of coronary arteries. Radiopharmaceuticals in neurological applications such as Alzheimer's disease, Parkinsons disease, and dementia are also being preferred by practitioners besides conventional treatment. Further, upcoming radioisotopes such as Ra-223 (Alpharadin) and Ga-68 possess huge potential for clinical applications.

Increasing use of SPECT and PET scans, technical advancements in equipment and other factors such as rising awareness of radiopharmaceuticals among physicians, alpha radioimmunotherapy based targeted cancer treatment, and ready availability of nuclear medicinemarket from cyclotrons have driven the market. High cost of devices using radioisotopes, short half-life, lack of good manufacturing practices, and stringent regulatory approvals are major hurdles to growth of the market.

See the rest here:

Global Nuclear Medicine / Radiopharmaceuticals Market worth $5.55 Billion by 2017

POSTED: Wednesday, March 27, 2013 - 8:00pm

UPDATED: Wednesday, March 27, 2013 - 8:14pm

Longview, TX (Good Shepherd Medical Center) The Internal Medicine Residency Program at Good Shepherd Medical Center, sponsored by the UT Health Northeast, is pleased to announce that the next 18 candidates have been selected and matched and will be joining the East Texas community this summer. The National Resident Match Program conducted its yearly match services last week, and on Friday, March 15, the second class of interns at the UT/GSMC Program were officially announced.

This years class is representative of US medical school graduates, US international medical graduates and international medical graduates, as listed specifically below:

Hana Altwal, MD University of Jordan Madhavi Annakula, MD Gandhi Medical College Leon Chen, DO UNTHSC TX College of Osteopathic Medicine Maria Chiejina, MD Igbinedion University Suyao Huang, MD Chicago Medical School at Rosalind Franklin University Ruth Jackson, MD UT San Antonio Jeffrey Kemp, MD UT Houston Zahi Merjaneh, MD University of Aleppo Nithin Nayini, MD St. Georges University Curtis Okpara, MD Ross University Yetsy Olusanya, MD Texas A&M Health Science Center Justin Oring, DO West Virginia School of Osteopathic Medicine Nadia Siddiqi, DO Des Moines University College of Osteopathic Medicine Mohammed Suhail, DO UNTHSC TX College of Osteopathic Medicine Carmen Tran, MD Ross University Jessica Vazquez, MD UT San Antonio Kyle Willingham, MD Texas Tech University Health Sciences Center Sudha Yanamandra, MD Guntur Medical College

We are very thankful to have received such a well-educated group of interns, said Dr. Emmanuel Elueze, Program Director for the Internal Medicine Residency Program. Already in the second year, we have become a highly-competitive program. We received more than 1,800 applications and had to narrow that down to 200 candidates to interview. We were successful in achieving our goals to attract and obtain high quality candidates with close ties to Texas, meaning that we will hopefully retain them as primary care givers in Texas after their training.

Ken Cunningham, interim chief executive officer for Good Shepherd Medical Center, said that this upcoming class proves that the program is headed in the right direction. Most of the candidates that we interviewed this year were US medical graduates, with a large percentage of them from Texas. The goal of our program is to train and keep primary care providers in Texas and going into our second year, we are on the right path.

The new interns will begin program orientation on June 17, and their first day of rotations will be Monday, July 1. The current class of interns will move to second-year residents and will act as upper-level supervisors to the interns, with the assistance of the current medical staff who act as attending physicians in the program.

The program will begin to receive applications for the 2014-2015 academic year in September, and interviews for the third class of residents at Good Shepherd Medical Center will be conducted from November to January. The program match occurs each March for the next academic year. The academic year runs from July to June.

If you would like more information on the UT/GSMC Internal Medicine Residency Program, please visit http://www.gsmc.org/residency. In addition to the incoming interns, a new class of third-year medical students will begin in July as well. Good Shepherd will welcome 12 students who will reside in Longview for the academic year and complete their third-year clerkships, which include internal medicine, family medicine, surgery, psychiatry, osteopathic manipulative medicine, obstetrics/gynecology and pediatrics.

Read more:

2013-2014 Interns named for GSMC Internal Medicine Residency Program

As more patients turn to UnitedPatientsGroup.com for trustworthy information about medical marijuana and alternative pain medicine, the reputable website extends its reach with the addition of a new Naturopathic Medicine page.

San Francisco, CA (PRWEB) March 30, 2013

Conveniently housed in one online location, the new Naturopathic Medicine page includes information regarding naturopathic doctors, therapies and remedies categorized by ailment. For example, patients with breast cancer can see what naturopathic nutrition, lifestyle and supplemental remedies are available for them all on one page.

Were dedicated to bringing awareness and education to patients who are in search of natural alternatives to traditional medical treatments, said John Malanca, founder and owner of United Patients Group. This new page will allow us to delve even further into this much needed education.

The Naturopathic Medicine page covers natural remedies for ailments ranging from seasonal blues and flu season to prostate cancer and HPV. Each ailments own separate page goes further into detail about causes and suggested natural remedies.

Patients suffering from migraine headaches can see what triggers the effects of this debilitating condition, what foods to avoid, what a sample treatment plan would look like if they visited a naturopathic doctor and other useful information.

From another angle, patients interested in finding out more about therapies like ultraviolet blood irradiation (UBI) can see comprehensive information about the procedure and its benefits at the click of a button.

The information contained in the Naturopathic Medicine section has been carefully selected from professional sources to ensure the highest level of quality and benefit of patients.

UnitedPatientsGroup.com has several ties to the medical community and seeks to highlight the newest discoveries within the alternative medicine industry in addition to proven clinical methods.

For more information about United Patients Group and the new Naturopathic Medicine section, call (415) 524-8099 or visit UnitedPatientsGroup.com.

See original here:

Medical Marijuana Resource UnitedPatientsGroup.com Adds New Naturopathic Medicine Page

Traditional Chinese medicine could be a key weapon in the treatment of type 2 diabetes, a joint international study has found.

TCM in addition to conventional drugs could be modern medicines best way of treating type 2 diabetes, a joint international study has revealed.

Researchers, including The University of Queenslands Dr Sanjoy Paul and Peking Universitys Professor Lilong Ji from Beijing, have found that conventional drugs were significantly more effective when used alongside traditional Chinese medicine in the treatment of type 2 diabetes.

The study involved a controlled clinical trial of 800 type 2 diabetic adults, comparing anti-diabetic drug Glibenclamide as a stand-alone treatment and treatment with Glibenclamide in conjunction with traditional Chinese medicine.

Dr Paul, who is Director of the Queensland Clinical Trials and Biostatistics Centre in UQs School of Population Health, said results showed patients treated with traditional Chinese medicine were more than a third less likely to experience hypoglycaemia dangerously low levels of blood sugar than those treated with Glibenclamide only.

They were also less likely to experience other symptoms of diabetes, including fatigue, hunger and palpitation, Dr Paul said.

Traditional Chinese medicine has long been used to treat diabetes in China and around the world but until now there has been a lack of evidence regarding its safety and efficacy.

This absence of scientific understanding has caused scepticism and criticism about traditional Chinese medicine.

Dr Paul said that more studies were needed to interpret just how traditional Chinese medicine worked to reduce hypoglycaemia, but the study results highlighted its potential to reduce the treatment gap in developing countries where diabetes was at epidemic proportions.

A vast majority of people in developing countries depend on herbal medicine for basic health care, Dr Paul said.

Continued here:

Chinese medicine may hold the key to treating diabetes

HOUSTON, TX--(Marketwire - March 29, 2013) - The board certified orthopedic and sports medicine specialists of Methodist Orthopedics & Sports Medicine are featured in the free Hot Topics Physician Lecture Series atMethodist Willowbrook Hospital, to educate the community on reducing risks, recognizing symptoms and properly treating injuries and conditions affecting the hand and wrist and the neck and spine.

Recognized physicians in their area of specialty, Dr. Korsh Jafarnia, will talk about common hand and wrist conditions in an April 10 session, 5:30 - 6:30 and Dr. HoSun Hwang, will talk about relieving back and neck pain on April 17, 6:00 - 7:30 p.m. Both sessions are free and open to the community, though spaces fill quickly so register today at 281.737.2500.The series is located in the Women's & Children's Pavilion, Conference Center on the Willowbrook campus, at 18220 State Highway 249. Refreshments and door prizes are included.

"We are pleased to bring this level of expertise to the community.Our physicians are passionate about education and outreach efforts -- and our Hot Topics series is a great opportunity for them to educate the public about the latest advancements and treatment options available in health care and answer questions the public may have," said Beryl Ramsey, CEO of Methodist Willowbrook Hospital and senior vice president of The Methodist Hospital System.

"We enjoy sharing valuable information about what we're seeing everyday, as well as meeting members of the community and hearing what really concerns them.These sessions are a great opportunity for everyone to walk away with a better understanding," said Dr. Jafarnia. Dr. Jafarnia is Board Certified and Fellowship trained in hand and upper extremity surgery -- completing his residency at Baylor College of Medicine and Fellowship in Hand Surgery at Harvard Medical School -- Massachusetts General Hospital.He holds a certificate of added qualifications in surgery of the hand (CAQSH) and has studied advanced techniques at the French Institute for Hand Surgery in Paris.

Dr. Hwang is Board Certified and Fellowship trained in spinal surgery -- completing his residency at Baylor College of Medicine and Fellowship in Spinal Disorders at the University of California Davis Medical Center.

Both of these physicians are recognized among Texas Super Doctors and provide comprehensive care and rehabilitation therapies onsite at the 25,000 square foot orthopedic and sports medicine center, which includes a new state-of-the-art Hand Center and Spine Center.

To learn more about these physicians and the upcoming Hot Topics in orthopedics and sports medicine go to http://www.methodistorthopedics.com. Call to reserve a spot, 281.737.2500.Check us out on Facebook .

For more information on the comprehensive services available on the Methodist Willowbrook Hospital campus, please visit http://www.methodistwillowbrook.com. For a physician referral, call (281) 737-2500.

See the original post:

Methodist Orthopedics & Sports Medicine Specialists Featured in Free Hot Topics Series at Methodist Willowbrook

[NV] [JL] [AF] Jumanji - Medicine [Emazinglights.com]
Nu Vision Jedi Lights Artistic Flow SoFlo.

By: NVShadowNV

Go here to read the rest:

[NV] [JL] [AF] Jumanji - Medicine [Emazinglights.com] - Video